Increased interleukin-4 production by NK T cells in systemic lupus erythematosus

Clinical Immunology

Volumn 92, Issue 2, 1999, Pages 197-202

  Funauchi, M ^a   Yu, H ^a   Sugiyama, M ^a   Ikoma, S ^a   Ohno, M ^a   Kinoshita, K ^a   Hamada, K ^a   Kanamaru, A ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Interleukin 4; NK T cells; Systemic lupus erythematosus

Indexed keywords

INTERLEUKIN 4;

ADULT; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; GROWTH REGULATION; HELPER CELL; HUMAN; IMMUNOPATHOGENESIS; LYMPHOCYTE DIFFERENTIATION; NATURAL KILLER CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032804991     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4742     Document Type: Article

References (33)

1. Tsokos G. C., Boumpas D. T., Smith P. L., Smith P. L., Djeu J. Y., Balow J. E., Rook A. H. Deficient gamma-IFN production in patients with SLE. Arthritis Rheum. 29:1986;1210-1215.
2. Tsokos G. C., Balow J. E. Cellular immune responses in systemic lupus erythematosus. Prog. Allergy. 35:1984;93-161.
3. Linker-Israeli M., Bakke A. C., Kitridou R. C., Gender S., Horwitz D. A. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J. Immunol. 130:1983;2651-2655.
4. Alcocer-Varela J., Alarcon-Segovia D. Longitudinal study of on the production and cellular response to interleukin 2 in patients with systemic lupus erythematosus. Rheumatol. Int. 15:1995;57-63.
5. Gajewski T. F., Joyce J., Fitch F. W. Antiproliferative effect of IFN gamma in immune regulation. III. Differential selection of Th1 and Th2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma. J. Immunol. 143:1989;15-22.
6. Ferdinandez B. R., Sanders V. M., Mosmann T. R., Vietta E. S. Lymphokine-mediated regulation of the proliferative response of clones of T helper and T helper 2 cells. J. Exp. Med. 168:1988;543-558.
7. Chang T. L., Shea C. M., Uriote S., Thompson R. C., Boom W. H., Abas A. K. Heterogeneity of helper/inducer T lymphocytes. III. Responses of IL-2- and IL-4-producing (Th1 and Th2) clones to antigens presented by different accessory cells. J. Immunol. 145:1990;2803-2808.
8. Romagnani S., Parronchi P., D'Elios M. M., Romagnani P., Annuziato F., Piccinni M. P. An update on human Th1 and Th2 cells. Int. Arch. Allergy Immunol. 113:1997;153-156.
9. Le Gros G., Ben Sasson S. Z., Sedar R., Finkelman F. D., Paul W. E. Generation of IL-4-producing cells in vivo and in vitro: IL-2 and IL-4 are required for the in vitro generation of IL-4 producing cells. J. Exp. Med. 172:1990;921-929.
10. Mosmann T. R. Cytokine: Is there biological meaning? Curr. Opin. Immunol. 3:1991;311-315.
11. Powrie F., Coffman R. S. Cytokine regulation of T-cell function: Potential for therapeutic intervention. Immunol. Today. 14:1993;270-275.
12. Nabors G. S., Farrel J. P. Successful chemotherapy in experimental Leishmaniasis is influenced by the polarity of the T cell response before treatment. J. Infect. Dis. 173:1995;979-986.
13. Funauchi M., Ikoma S., Enomoto H., Horiuchi A. Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus. Scand. J. Rheumatol. 27:1998;219-224.
14. + T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J. Immunol. 143:1989;103-112.
15. Sakamoto A., Sumida T., Maeda T., Itoh M., Asai T., Takahashi H., Yoshida S., Koike T., Tomioka H., Yoshida S. T cell receptor V receptor/expression double-negative T cells in patients with systemic sclerosis. Arthritis Rheum. 35:1992;944-948.
16. + T cells that promptly produce interleukin 4. Proc. Natl. Acad. Sci. USA. 92:1995;11931-11934.
17. + cells in a Th2 response and in immunoglobulin E production. Science. 270:1995;1845-1847.
18. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1982;1271-1277.
19. Liang M. H., Socher S. A., Roberts W. N., Esdaile J. M. Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum. 31:1988;817-825.
20. Sumida T., Sakamoto A., Murata H., Makino Y., Takahashi H., Yoshida S., Nishioka K., Iwamoto I., Taniguchi M. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J. Exp. Med. 182:1995;1163-1168.
21. Schmidt R. E., Murray C., Daley J. F., Schlossman S. F., Ritz J. A subset of natural killer cells in peripheral blood displays a mature T cell phenotype. Exp. Med. 164:1986;351-356.
22. Moingeon P., Jitsukawa S., Faure F., Troalen F., Triebel F., Graziani M., Forestier F., Bellet D., Bohuon C., Hercend T. A gamma-chain complex form unctional receptor on cloned human lymphocytes with natural killer activity. Nature. 325:1987;723-726.
23. Michon J. M., Caligiuri M. A., Hazanow S. M., Levine H., Schlossman S. F., Ritz J. Induction of natural killer effectors from human thymus with recombinant IL-2. J. Immunol. 140:1988;3660-3667.
24. Brinkmann V., Kristofic C. Massive production of Th2 cytokines by human CD4 effector T cells transiently expressing the natural killer cell marker CD57/HNK. Immunology. 91:1997;541-547.
25. Leit-de-Moraes M. C., Dy M. Natural killer T cells: A potent cytokine-producing cell population. Eur. Cytokine Netw. 8:1997;229-237.
26. Gold J. E., Lous-Charles A., Ghali V., Babu A., Little J. R., Athan E., Knowles D. M., Zalusky R. T-cell chronic lymphocytic leukemia. Unusual morphologic, phenotypic and karyotypic features in association with light chain amyloidosis. Cancer. 70:1992;86-93.
27. + T cells which increase at tumors in patients with colorectal cancer. Clin. Exp. Immunol. 102:1995;159-166.
28. - cells, in autoimmune thyroid disease. Clin. Exp. Immunol. 93:1993;430-436.
29. Krenger W., Ferrara J. L. Graft-versus-host disease and the Th1/Th2 paradigm. Immunol. Res. 15:1996;50-73.
30. Inagawa H., Nishizawa T., Honda T., Nakamoto T., Takagi K., Soma G. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: Involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions. Anticancer Res. 18:1998;3957-3964.
31. Sato M., Goto S., Ito M., Sato S., Takeuchi S. Impaired production of Th1 cytokines and increased frequency of Th2 subsets in PBMC from advanced cancer patients. Anticancer Res. 18:1998;3951-3955.
32. Takeuchi T., Ueki T., Sasaki Y., Kajiwara T., Li B., Moriyama N. Th2-like response and antitumor effect of anti-interleukin-4 mAb in mice bearing renal cell carcinoma. Cancer Immunol. Immunother. 43:1997;375-381.
33. Meyaard L., Hovenkamp E., Keet I. P., Hooibrink B., de Jong I. H., Otto S. A. Single cell analysis of IL-4 and IFN-gamma production by T cells from HIV-infected individuals: decreased IFN-gamma in the presence of preserved IL-4 production. J. Immunol. 157:1996;2712-2718.